Supplemental material
Expert Review of Vaccines
Volume 22, 2023 - Issue 1
Original Research
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data
Jingyan Yanga Pfizer Inc, New York, NY, USA;b Institute for Social and Economic Research and Policy, Columbia University, New York, NY, USACorrespondence[email protected]
https://orcid.org/0000-0001-5523-649XView further author information
https://orcid.org/0000-0001-5523-649XView further author information, Shailja Vaghelac HealthEcon Consulting Inc, Ancaster, ON, Canadahttps://orcid.org/0000-0001-8606-5304View further author information
https://orcid.org/0000-0001-8606-5304View further author information, , , Manuela Di Fuscoa Pfizer Inc, New York, NY, USAhttps://orcid.org/0000-0003-0079-7331View further author information
https://orcid.org/0000-0003-0079-7331View further author information, , Moe H. Kyawa Pfizer Inc, New York, NY, USAhttps://orcid.org/0000-0002-7633-271XView further author information
https://orcid.org/0000-0002-7633-271XView further author information, & show all